Although these studies demonstrate that vaccination by predictive NeoAg filtration is generally feasible for the treatment of metastatic melanoma, it is unclear if the inclusion of epitopes yielding no IFN-γ response or those eliciting single CD4+ or CD8+ T cell responses negatively impact vaccine design via antigenic competition for MHC presentation (27). This evidence concerns the gene CD8A and metastatic melanoma.